Page 11 - HIV/AIDS Guidelines

HHS Panel on Antiretroviral Guidelines for Adults and
Adolescents Financial Disclosure (Last updated October 14, 2011; last

reviewed October 14, 2011)

Panel
Name Company Relationship
Status*
John G. Bartlett C None N/A

John T. Brooks M None N/A
Victoria Cargill M None N/A
Laura Cheever M None N/A
Lei Chou M Bristol-Myers Squibb • Travel Support
Genentech/Roche • Travel Support
Janssen Therapeutics • Travel Support
(formerly Tibotec Therapeutics)
Merck • Travel Support
Deborah L. Cohan M None • N/A
Eric Daar M Abbott • Research Support
Bristol-Myers Squibb • Consultant
Gilead • Advisory Board, Research Support
Merck • Consultant, Research Support
ViiV • Consultant, Research Support

Paul Dalton M None N/A
Steven G. Deeks M Bristol-Myers Squibb • Research Support
Gilead • Research Support
GlaxoSmithKline • Advisory Committee
Hoffmann-La Roche • Advisory Board, Travel Support
Merck • Research Support, Travel Support
Tobira • Advisory Board
ViiV • Advisory Committee

Carlos del Rio M Merck • Research Support
Sanofi Pasteur • Research Support

Robert T. Dodge M Abbott • Advisory Board, Speakers' Bureau,
Consultant
Boehringer Ingelheim • Advisory Board, Speakers' Bureau,
Consultant
Gilead • Advisory Board, Speakers' Bureau,
Consultant
ViiV • Advisory Board, Speakers' Bureau,
Consultant
Courtney V. Fletcher M Bristol-Myers Squibb • Advisory Board
Merck • Advisory Board
Gerald Friedland M Bristol-Myers Squibb • Research Support
Merck • Research Support

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents ix

Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.